300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Art
Digital Media
FinTech
Finance
Real Estate
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Sporting Goods
Internet
Android
Sustainability
Hardware
Biotech
Enterprise
Impact
Proptech
Community
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Gibraltar
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 10 Biotech Angel Investors in Denmark (August 2026)

The most active angel investors investing in Denmark Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Denmark Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Per Falholt
Angel
4 Denmark Pre-Seed, Series A, Seed Biotechnology, Robotics, Biopharma $5.9M–$20M
Nicholas Francis
Angel
3 Denmark, United States Seed, Series A SaaS, Robotics, Software $983k–$8.1M
Steen Riisgaard
Angel
2 Denmark Pre-Seed, Series A Biotechnology, Biopharma, Wholesale
Bruce Linton
Angel
2 Canada, United States, Denmark Post-IPO Equity, Seed, Pre-Seed Cannabis, Health Care, Biotechnology $40k–$53M
Giampaolo Cagnin
Angel
2 Italy, Denmark Seed, Pre-Seed Chemical, Biotechnology, Food and Beverage $4.9M–$7.6M
Martin Tromp Permin
Angel
1 Denmark Seed Robotics, Biotechnology, Machine Learning
Peter Sandberg
Angel
1 Denmark, Kenya, Estonia Angel, Pre-Seed, Secondary Market Internet, Mobile Payments, Artificial Intelligence
Roland Berger
Angel
1 Germany, Denmark, Switzerland Series A, Series B Financial Services, Information Services, Apps $4.9M–$30M
David Helgason
Angel
1 United States, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Artificial Intelligence $242k–$30M
Charlie Songhurst
Angel
1 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $542k–$8.5M
Access all 25 angel investors in Denmark Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Per Falholt
Angel · Copenhagen, Hovedstaden, Denmark · 4 investments in Denmark Biotech startups

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Biopharma
  • Stage:Pre-Seed, Series A, Seed
  • Geography: Denmark

Investor stats

  • Total investments: 5
  • Round size: Series A $5.9M–$20M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Nicholas Francis
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotech startups

Nicholas Francis is based out of Copenhagen, Hovedstaden, and is the Founder of Francis Family Funds. Nicholas previously worked at framebunker as a Co-Founder.

Show more...

Investment focus

  • Industry: SaaS, Robotics, Software
  • Stage:Seed, Series A
  • Geography: Denmark, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $983k–$8.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Waterplan — Waterplan creates a water resilience planning platform for managing water availability in facilities. The company employs artificial intelligence to automatically collect operational data from businesses and combine it with local water satellite imagery to provide a real-time financial assessment of water risk and to offer modified mitigation andadaptation options.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Steen Riisgaard
Angel · 2 investments in Denmark Biotech startups

Steen Riisgaard

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Wholesale
  • Stage:Pre-Seed, Series A
  • Geography: Denmark

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Bruce Linton
Angel · Ottawa, Ontario, Canada · 2 investments in Denmark Biotech startups

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Show more...

Investment focus

  • Industry: Cannabis, Health Care, Biotechnology
  • Stage:Post-IPO Equity, Seed, Pre-Seed
  • Geography: Canada, United States, Denmark

Investor stats

  • Total investments: 8
  • Round size: Seed $1.8M–$5M; Post-IPO Equity $40k–$53M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • SynBiotic — SYNBIOTIC SE is a leading European corporate group operating in the dynamic environment of the industrial hemp and cannabis market.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Martello Technologies — Prioritize and resolve performance problems and optimize the Microsoft 365 and Teams user experience with Martello Vantage DX.
Show all investments...

Giampaolo Cagnin
Angel · Parma, Emilia-Romagna, Italy · 2 investments in Denmark Biotech startups

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

Show more...

Investment focus

  • Industry: Chemical, Biotechnology, Food and Beverage
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Denmark

Investor stats

  • Total investments: 3
  • Round size: Seed $4.9M–$7.6M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
  • Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
Show all investments...

Martin Tromp Permin
Angel · Los Angeles, California, United States · 1 investments in Denmark Biotech startups

Martin Permin is a CEO at Pelion in the USA.

Show more...

Investment focus

  • Industry: Robotics, Biotechnology, Machine Learning
  • Stage:Seed
  • Geography: Denmark

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Peter Sandberg
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Denmark Biotech startups

Peter Sandberg is a Co-Founder of Nordic Secondary Fund, and a venture partner at Startup Wise Guys. He has extensive experience as a Business Angel, Asset Management and Wealth Management

Show more...

Investment focus

  • Industry: Internet, Mobile Payments, Artificial Intelligence
  • Stage:Angel, Pre-Seed, Secondary Market
  • Geography: Denmark, Kenya, Estonia

Investor stats

  • Total investments: 17
  • Lead/follow: no public data

Portfolio highlights

  • TRAPMINE — TRAPMINE Endpoint Protection Platform provides fool-proof defense against malware, exploit attempts, file-less malware, ransomware and other forms of targeted attacks.Unlike traditional detection-based approaches like legacy antivirus, TRAPMINE combines proven and innovative technologies such as deep learning, behavior monitoring, endpointdeception and anti-exploit techniques to block cyber threats dead in their tracks. TRAPMINE's easy-deploy and lightweight solution comes with a comfortable built-in security console, at a price/performance ratio unmatchable even by the biggest names in Palo Alto.Why TRAPMINE?Cyber criminals target companies of all sizes from every industry, seeking anything that might be of value. Antivirus and other traditional security solutions are no longer efficient to protect organizations from attacks by today’s modern cyber threat actors. That’s why we founded TRAPMINE. TRAPMINE is created to solve the malware problem for all organizations at a reasonable price.
  • Colibo A/S — Use Colibo's intranet software as your enterprise collaboration platform to increase productivity, drive employee engagement and better internal communications.
  • November First — November First - Betalingsplatform til alle virksomheder
Show all investments...

Roland Berger
Angel · Munich, Bayern, Germany · 1 investments in Denmark Biotech startups

Roland Berger is a Founder of Roland Berger, Munich and has been the Roland Berger GmbH's Honorary Chairman since 2010. Today, Roland Berger has grown to become one of the world's top five strategy consulting firms with 50 offices in 36 countries. The company has a workforce of 2,400 and advises leading international industrial andservice enterprises, as well as public institutions. From the company's foundation in 1967 until 2003, Roland was Chief Executive Officer of the firm, and until 2010 Chairman of the Supervisory Board. Prior to founding his strategy consultancy, Roland was employed as a consultant and ultimately partner at a leading American consulting firm based in Milan and Boston. Roland has been appointed to various expert commissions by several German state governments and the federal government. From 2007 to its dissolution in 2014, Roland was a Member of the High Level Group on Administrative Burdens under the leadership of former Bavarian State Premier Dr. Edmund Stoiber, appointed by the European Commission. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations, including Fresenius SE & Co. KGaA (Chairman of the Audit Committee), Bad Homburg; Prime Office REIT-AG, Munich (Chairman of the Supervisory Board); RCS Mediagroup S.p.A.(Vice-President), Milan, Italy. Roland also serves on several international advisory boards, including those of Deutsche Bank AG in Frankfurt, MillerBuckfire in New York and The Blackstone Group in New York. Since 1996 Roland has been a Lecturer and Visiting Professor and since 2000 Honorary Professor for Business Administration and Management Consulting at the Brandenburg Technical University in Cottbus. Furthermore, Roland was appointed a member of the Oxford Martin Commission for Future Generations in 2012. Since 2002, Roland has been on the Business Advisory Council of the State Premier of Saxony-Anhalt and was appointed to the Globalization Council Portugal by the Portuguese President Aníbal Cavaco Silva. Previously, German President Roman Herzog had appointed Roland to the President's Advisory Council for Innovation. Roland has also actively participated in over 20 federal government commissions under Helmut Kohl and Gerhard Schröder. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations and invests in many private and listed companies as well as startups. Roland was Honorary Consul General of the Republic of Finland in Bavaria and Thuringia from 1996 to 2015. Roland is Chairman of the Board of Trustees of the Roland Berger Foundation, which he set up personally with an endowment of EUR 50 million. The Roland Berger Foundation is dedicated to the global protection of human dignity and human rights. Each year it confers the Roland Berger Award for Human Dignity. The Foundation also helps gifted children and young people from underprivileged families across Germany and Italy to gain access to the best possible primary and secondary education. Outside work, Roland pursues his interest in modern art and owns a large collection of artworks, mainly by contemporary artists from Europe, the US, South America and China. Roland also loves classical music and supports the Mahler Chamber Orchestra and Bavarian State Opera, among others. Roland loves hiking and cross-country skiing, especially in the Swiss region of Engadin. Roland studied business administration in Munich and Hamburg. (MBA from the Ludwig-Maximilians-Universität, Munich).

Show more...

Investment focus

  • Industry: Financial Services, Information Services, Apps
  • Stage:Series A, Series B
  • Geography: Germany, Denmark, Switzerland

Investor stats

  • Total investments: 8
  • Round size: Series A $4.9M–$30M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Flip — The AI employee app for frontline workers without a company email. Flip unites internal comms, HR self-service and AI workflows in one platform. Book a demo.
  • Balance Re — Scaling the power of ALM
  • RSP Systems — RSP Systems is developing a non-invasive glucose monitor, GlucoBeam(R), which will ease the lives of people with diabetes world-wide by providing convenient, pain-free glucose monitoring.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Denmark Biotech startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 79
  • Round size: Seed $1.1M–$8M; Pre-Seed $242k–$2.4M; Series A $4.3M–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • ScyAI — Risk intelligence that thinks with you.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 1 investments in Denmark Biotech startups

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 214
  • Round size: Seed $1.1M–$8.5M; Pre-Seed $542k–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
  • Uncovr — Surgical video is the biggest dark data in medicine. We turn it into operative reports, billing codes, and clinical intelligence automatically
  • Structured AI — Construction AI QA/QC software that automatically reviews drawing packages and catches errors, code issues, and coordination clashes before they reach the field.
Show all investments...

Biotech Angel investor funding in Denmark at a glance

Stats across 22 deals from 25 investors.

25
investors
in Denmark Biotech startups
22
deals
in Denmark Biotech startups
$7.1M
median round
in Denmark Biotech startups
20%
lead investors
lead at least one round
27%
Seed
most common funding stage

Access all 25 angel investors in Denmark Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 25 angel investors investing in Denmark Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists